NEPH News and Press, Nephros Inc. From 02/29/24

SOUTH ORANGE, NJ - ( NewMediaWire ) - February 29, 2024 -   Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth quarter and fiscal year financial results on Thursd...

Nephros, Inc. (NASDAQ: NEPH) is one of today's top gainers. The company's shares have moved 0.5% on the day to $1.61. Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filt...

2023-12-13 10:00:34 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Motus GI, C4 T...

2023-12-12 14:09:20 ET More on Nephros Nephros Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Nephros Historical earnings data for Nephros Financial information for Nephros For further details see: Nephros CEO buys 18k sha...

2023-11-10 05:26:02 ET Nephros, Inc. (NEPH) Q3 2023 Earnings Conference Call November 08, 2023, 04:30 PM ET Company Participants Kirin Smith - PCG Advisory Robert Banks - CEO Judy Krandel - Chief Financial Officer Andy Astor - Advisor and Interim CFO Co...

2023-11-08 17:42:10 ET More on Nephros Seeking Alpha’s Quant Rating on Nephros Historical earnings data for Nephros Financial information for Nephros For further details see: Nephros GAAP EPS of -$0.02 beats by $0.05, revenue of $3.74M beats by $0.37M

Third-Quarter Net Revenue of $3.7 Million, a 55% Increase Over 2022; Net Loss from Continuing Operations Narrows 85% to $0.2 Million; $1.1 Million in Positive Year-to-Date Net Cash Flows from Operating Activities SOUTH ORANGE, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire &...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

2023-11-01 07:42:22 ET More on Nephros Seeking Alpha’s Quant Rating on Nephros Historical earnings data for Nephros Financial information for Nephros For further details see: Nephros hires Judy Krandel as Chief Financial Officer

SOUTH ORANGE, NJ - ( NewMediaWire ) - November 01, 2023 -   Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, announced the appointment of Judy Krandel as Chief Financial Officer (CFO), effective to...